Techno Medica Co., Ltd. (TYO:6678)

Market Cap	13.42B
Revenue (ttm)	9.66B
Net Income (ttm)	846.48M
Shares Out	6.93M
EPS (ttm)	122.18
PE Ratio	15.85
Forward PE	n/a
Dividend	68.00 (3.49%)
Ex-Dividend Date	Mar 28, 2025

Volume	7,000
Average Volume	5,865
Open	1,952.00
Previous Close	1,947.00
Day's Range	1,936.00 - 1,960.00
52-Week Range	1,580.00 - 2,035.00
Beta	0.05
RSI	69.55
Earnings Date	Aug 6, 2025

About Paramount Global

Techno Medica Co., Ltd. engages in the research and development, manufacture, sale, import, and export of in-vitro diagnostic analyzers in Japan. The company offers automated tube selecting and labeling systems, RFID specimen management, inspection reception systems, reception and collation systems, automated urine aliquot and labeling systems, pre-analytical instruments, and blood and urine collection support, as well as blood gas, electrolytes, erythrocyte sedimentation rates, and ion selective electrode-certificated serums. It also provides ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1987
• Employees: 244
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 6678

Financial Performance

In 2024, Techno Medica's revenue was 9.91 billion, a decrease of -3.68% compared to the previous year's 10.28 billion. Earnings were 1.00 billion, a decrease of -25.52%.